SMUG1 and colonic neoplasm: Moreover, three patients with inactivating mutations in SMUG1 (Q93K, R187*, and R220W) demonstrated a 33% four-year survival rate after colon cancer diagnosis, compared to over 90% survival in patients without the mutations.